# REGENERON PHARMACEUTICALS, INC. (REGN) FY2025 Annual P&L / Income Statement

- Company: REGENERON PHARMACEUTICALS, INC. (REGN)
- Period: 2025-01-01 to 2025-12-31
- Filing: FY2025 10-K, filed 2026-02-04, accession number 0000872589-26-000008
- Page: https://plicit.ai/financials/regn/fy2025-annual-income-statement
- Chart image: https://plicit.ai/charts/regn-fy2025-annual-income-statement-sankey.png

## Chart details: Revenue by Product and Service by Geography

Income statement for 2025-01-01 through 2025-12-31. View: Product and Service by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue from contract with customer**: 14,342,900,000 US dollars
- **Cost of revenue (calculated)**: 2,100,700,000 US dollars
- **Gross profit (calculated)**: 12,242,200,000 US dollars
- **Operating expenses (calculated)**: 8,664,300,000 US dollars
- **Income from operations**: 3,577,900,000 US dollars
- **Total other income (expense)**: 1,652,800,000 US dollars
- **Income before income taxes**: 5,230,700,000 US dollars
- **Income tax expense**: 725,800,000 US dollars
- **Net income**: 4,504,900,000 US dollars
- **Other products**: 10,100,000 US dollars
- **ELYEA HD And EYLEA - UNITED STATES**: 4,384,700,000 US dollars
- **ELYEA HD - UNITED STATES**: 1,636,900,000 US dollars
- **Evkeeza - UNITED STATES**: 162,200,000 US dollars
- **EYLEA Net Product Sales - UNITED STATES**: 2,747,800,000 US dollars
- **Inmazeb - UNITED STATES**: 37,400,000 US dollars
- **Libtayo - UNITED STATES**: 944,700,000 US dollars
- **Libtayo - Rest of world**: 507,500,000 US dollars
- **Praluent - UNITED STATES**: 262,500,000 US dollars
- **Undisclosed (calculated)**: 3,649,100,000 US dollars
- **Cost of goods sold and of collaboration and contract manufacturing**: 2,100,700,000 US dollars
- **Other operating (income) expense, net**: negative 10,000,000 US dollars
- **Acquired in-process research and development**: 124,100,000 US dollars
- **Research and development**: 5,850,200,000 US dollars
- **Selling, general, and administrative**: 2,700,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service (3 categories)

- Page: https://plicit.ai/financials/regn/fy2025-annual-income-statement/revenue-by-product-and-service-3-categories
- Chart image: https://plicit.ai/charts/regn-fy2025-annual-revenue-by-product-and-service-3-categories-sankey.png

Income statement for 2025-01-01 through 2025-12-31. View: Product and service (3 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue from contract with customer**: 14,342,900,000 US dollars
- **Cost of revenue (calculated)**: 2,100,700,000 US dollars
- **Gross profit (calculated)**: 12,242,200,000 US dollars
- **Operating expenses (calculated)**: 8,664,300,000 US dollars
- **Income from operations**: 3,577,900,000 US dollars
- **Total other income (expense)**: 1,652,800,000 US dollars
- **Income before income taxes**: 5,230,700,000 US dollars
- **Income tax expense**: 725,800,000 US dollars
- **Net income**: 4,504,900,000 US dollars
- **Net product sales**: 6,309,100,000 US dollars
- **Collaboration revenue**: 7,331,200,000 US dollars
- **Other revenue**: 702,600,000 US dollars
- **Cost of goods sold and of collaboration and contract manufacturing**: 2,100,700,000 US dollars
- **Other operating (income) expense, net**: negative 10,000,000 US dollars
- **Acquired in-process research and development**: 124,100,000 US dollars
- **Research and development**: 5,850,200,000 US dollars
- **Selling, general, and administrative**: 2,700,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service (2 categories)

- Page: https://plicit.ai/financials/regn/fy2025-annual-income-statement/revenue-by-product-and-service-2-categories
- Chart image: https://plicit.ai/charts/regn-fy2025-annual-revenue-by-product-and-service-2-categories-sankey.png

Income statement for 2025-01-01 through 2025-12-31. View: Product and service (2 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue from contract with customer**: 14,342,900,000 US dollars
- **Cost of revenue (calculated)**: 2,100,700,000 US dollars
- **Gross profit (calculated)**: 12,242,200,000 US dollars
- **Operating expenses (calculated)**: 8,664,300,000 US dollars
- **Income from operations**: 3,577,900,000 US dollars
- **Total other income (expense)**: 1,652,800,000 US dollars
- **Income before income taxes**: 5,230,700,000 US dollars
- **Income tax expense**: 725,800,000 US dollars
- **Net income**: 4,504,900,000 US dollars
- **Libtayo**: 1,452,200,000 US dollars
- **Other products**: 10,100,000 US dollars
- **Undisclosed (calculated)**: 12,880,600,000 US dollars
- **Cost of goods sold and of collaboration and contract manufacturing**: 2,100,700,000 US dollars
- **Other operating (income) expense, net**: negative 10,000,000 US dollars
- **Acquired in-process research and development**: 124,100,000 US dollars
- **Research and development**: 5,850,200,000 US dollars
- **Selling, general, and administrative**: 2,700,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.